Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
AZT | Oslo | NOK | Real-time | |
0DRV | London | NOK | Real-time | |
ARCZNOK | Stockholm | NOK | Real-time | |
B4V | Frankfurt | EUR | Delayed |
ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, In vitro diagnostics, and biomanufacturing. It offers salt active nuclease for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays; double-strand specific DNases and derived kits for the removal of double stranded DNA; polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining nucleic acids. It operates in Norway, Germany, Lithuania, Italy, other countries in Europe, the United States, and internationally. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was founded in 1990 and is headquartered in Tromsø, Norway.
Name | Age | Since | Title |
---|---|---|---|
Lill-Hege Henriksen | - | 2022 | Employee Elected Observer |
Jane Theaker | - | 2021 | Independent Director |
Bernd Striberny | - | 2021 | Independent Employee Elected Director |
Marie Ann Roskrow | - | 2018 | Executive Chairman |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review